Discover
MRVI
Maravai LifeSciences Holdings, Inc.
6.15
2 x 4.56
2 x 7.92
bid
ask
-
0.09
1.44%
2 @ 04:00 PM
6.20 +0.05 (0.81%)
| Ytd | 89.23% | |
| 1y | 132.08% |
6.12
day range
6.42
1.99
52 week range
6.55
| Open | 6.20 | Prev Close | 6.24 | Low | 6.12 | High | 6.42 | Mkt Cap | 2.27B |
| Vol | 2.21M | Avg Vol | 2.75M | EPS | -0.71 | P/E | N/A | Forward P/E | -67.10 |
| Beta | 0.71 | Short Ratio | 3.11 | Inst. Own | 88.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.65 | 200-d Avg | 3.65 | 1yr Est | 5.70 |
| Income Statement | |||
| Total Revenue | 65.84M | ||
| Revenues (USD) | 65.84M | ||
| Cost of Revenue | 32.14M | ||
| Gross Profit | 33.70M | ||
| Operating Expenses | 35.86M | ||
| Research and Development Expense | 3.89M | ||
| Selling, General and Administrative Expense | 29.09M | ||
| Operating Income | -2.16M | ||
| Interest Expense | 5.75M | ||
| Income Tax Expense | -151.00K | ||
| Net Income | -3.73M | ||
| Net Income Common Stock | -3.73M | ||
| Net Income Common Stock (USD) | -3.73M | ||
| Consolidated Income | -6.38M | ||
| Net Income to Non-Controlling Interests | -2.64M | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | 1.87M | ||
| Earning Before Interest & Taxes (USD) | 1.87M | ||
| Weighted Average Shares | 146.43M | ||
| Weighted Average Shares Diluted | 146.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 165.92M | ||
| Cash and Equivalents (USD) | 165.92M | ||
| Trade and Non-Trade Receivables | 33.42M | ||
| Current Assets | 251.74M | ||
| Property, Plant & Equipment Net | 146.93M | ||
| Total Assets | 713.22M | ||
| Debt Current | 5.44M | ||
| Total Debt | 270.88M | ||
| Current Liabilities | 42.62M | ||
| Debt Non-Current | 265.44M | ||
| Total Liabilities | 344.13M | ||
| Accumulated Retained Earnings (Deficit) | 6.39M | ||
| Accumulated Other Comprehensive Income | 466.00K | ||
| Shareholders Equity | 211.56M | ||
| Shareholders Equity (USD) | 211.56M | ||
| Assets Non-Current | 461.48M | ||
| Total Debt (USD) | 270.88M | ||
| Goodwill and Intangible Assets | 274.32M | ||
| Inventory | 40.46M | ||
| Liabilities Non-Current | 301.51M | ||
| Trade and Non-Trade Payables | 8.54M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 12.98M | ||
| Net Cash Flow from Financing | -55.23M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -50.97M | ||
| Capital Expenditure | -4.44M | ||
| Issuance (Repayment) of Debt Securities | -51.36M | ||
| Net Cash Flow from Investing | -4.44M | ||
| Net Cash Flow from Operations | 8.66M | ||
| Effect of Exchange Rate Changes on Cash | 30.00K | ||
| Share Based Compensation | 6.74M | ||